表紙
市場調查報告書

全球分子診斷市場:產業分析與預測

Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)

出版商 Koncept Analytics 商品編碼 248316
出版日期 內容資訊 英文 101 Pages
訂單完成後即時交付
價格
Back to Top
全球分子診斷市場:產業分析與預測 Global Molecular Diagnostics Market: Industry Analysis & Outlook (2018-2022)
出版日期: 2019年01月08日內容資訊: 英文 101 Pages
簡介

本報告提供全球分子診斷 (MD) 市場相關調查分析,以感染疾病 (HPV/披衣菌感染) 、遺傳基因檢驗為焦點,提供市場概要,市場動態,競爭情形,主要企業等系統性資訊。

第1章 市場概要

  • 診斷
  • 分子診斷
  • 分子診斷的目的

第2章 全球體外診斷 (IVD) 市場

  • 全球IVD市場:各金額
  • 全球IVD市場預測:各金額
  • 全球IVD市場:各市場區隔
  • 全球IVD市場:各技術

第3章 全球分子診斷 (MD) 市場

  • 全球MD市場:各金額
  • 全球MD市場預測:各金額
  • 全球MD市場:各用途
  • 全球MD市場預測:各地區
  • 全球MD市場:檢驗的各類型

第4章 各地區市場

  • 北美
  • 歐洲
  • 韓國

第5章 市場動態

  • 成長推動因素
  • 主要趨勢與發展
  • 課題

第6章 競爭情形

  • 全球IVD市場
  • 全球MD市場

第7章 企業簡介

  • Roche Holding
    • 產業概要
    • 財務概要
    • 產業策略
  • Abbott Laboratories
    • 產業概要
    • 財務概要
    • 產業策略
  • Hologic Inc.
    • 產業概要
    • 財務概要
    • 產業策略
  • Qiagen
    • 產業概要
    • 財務概要
    • 產業策略

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In vitro diagnostics (IVD) are the medical tests which are intended to perform diagnoses from sample of body fluids in a controlled environment outside a living organism. In vitro diagnostic (IVD) tests are performed to conduct diagnoses from assays in a test tube, or in a controlled environment outside a living organism.

Molecular Diagnostics (MD) is a technology used in the process of in vitro diagnosis. Molecular diagnostics involves the measurement of DNA, RNA, proteins or metabolites in order to detect genotypes, mutations or biochemical changes in the body. Molecular diagnostics market is escalating beyond the identification of infections. It is becoming an essential part of disease management and therapy. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine. The market is further expected to see a robust growth with increased research and development.

The global molecular diagnostics market is expected to see innovation driven growth. With recent outbreak of infectious diseases like Ebola and swine flu, they would require accurate diagnostics, which will instigate the growth of the molecular diagnostics technology in the future, thereby posing tremendous growth potential for the market.

The key factors driving growth of the MD market includes fast approvals for companion diagnostics reagents, increase in emergence of infectious disease, innovation and technical development, rising ageing population, and escalating global healthcare expenditure. However, there are certain factors hindering the growth of the market like high initial cost, obligation of skilled labor, and lack of proper healthcare infrastructure. The major trends featuring the market include progressing sample-to-answer molecular diagnostics market, growth in Point of Care Diagnostics (POCT), and emergence of Liquid Biopsy Solutions among others.

The report offers an in-depth analysis of the "Global Molecular Diagnostics Market". It covers the regional and global aspect of the market. Competition is concentrated in the hands of few major companies, of which Roche Holding AG, Abbott Laboratories, Danaher Corporation and Hologic Inc., have been covered in the report.

Table of Contents

1. Overview

  • 1.1 Diagnostics
  • 1.2 Molecular Diagnostics
  • 1.3 Purpose of Molecular Diagnostics

2. Global In-Vitro Diagnostics (IVD) Market

  • 2.1 Global IVD Market by Value
  • 2.2 Global IVD Market Forecast by Value
  • 2.3 Global IVD Market by Segment
  • 2.4 Global IVD Market by Technology

3. Global Molecular Diagnostics Market

  • 3.1 Global Molecular Diagnostics Market by Value
  • 3.2 Global Molecular Diagnostics Market Forecast by Value
  • 3.3 Global Molecular Diagnostics Market by Application
    • 3.3.1 Global Infectious Disease Testing Market by Value
    • 3.3.2 Global Infectious Disease Testing Market Forecast by Value
    • 3.3.3 Global Infectious Disease Testing Market Value by Type
    • 3.3.4 Global CT/NG Market by Value & Volume
    • 3.3.5 Global CT/NG Market Forecast by Value & Volume
    • 3.3.6 Global HPV Testing Market by Value & Volume
    • 3.3.7 Global HPV Testing Market Forecast by Value & Volume
    • 3.3.8 Global Oncology Testing Market by Value
    • 3.3.9 Global Oncology Testing Market Forecast by Value
    • 3.3.10 Global Blood Screening Testing Market by Value
    • 3.3.11 Global Blood Screening Testing Market Forecast by Value
    • 3.3.12 Global Genetic Testing Market by Value
    • 3.3.13 Global Genetic Testing Market Forecast by Value
  • 3.4 Global Molecular Diagnostics Market by Technology
  • 3.5 Global Molecular Diagnostics Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Molecular Diagnostics Market by Value
    • 4.1.2 North America Molecular Diagnostics Market Forecast by Value
    • 4.1.3 North America Molecular Diagnostics Market by Application
    • 4.1.4 North America Oncology Based Molecular Diagnostics Market by Value
    • 4.1.5 North America Oncology Based Molecular Diagnostics Market Forecast by Value
    • 4.1.6 North America Oncology Based Molecular Diagnostics Market by Product
    • 4.1.7 North America Oncology Based Reagents Market by Value
    • 4.1.8 North America Oncology Based Reagents Market Forecast by Value
    • 4.1.9 North America Oncology Based Instruments Market by Value
    • 4.1.10 North America Oncology Based Instruments Market Forecast by Value
  • 4.2 Western Europe
    • 4.2.1 Western Europe Molecular Diagnostics Market by Value
    • 4.2.2 Western Europe Molecular Diagnostics Market Forecast by Value
    • 4.2.3 Western Europe Molecular Diagnostics Market by Application
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Molecular Diagnostics Market by Value
    • 4.3.2 Asia Pacific Molecular Diagnostics Market Forecast by Value
    • 4.3.3 Asia Pacific Molecular Diagnostics Market by Application

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Fast Approvals for Companion Diagnostics (CD) Reagents
    • 5.1.2 Rising Emergence of Infectious Diseases
    • 5.1.3 Rise in Global Ageing Population
    • 5.1.4 Increasing Incidence of Cancer Cases
    • 5.1.5 Rising Global Healthcare Expenditure
  • 5.2 Key Trends and Developments
    • 5.2.1 Progressing Sample-to-Answer Molecular Diagnostics Market
    • 5.2.2 Growth in Point of Care Diagnostics (POCT)
    • 5.2.3 Booming Medical Devices Industry
    • 5.2.4 Innovation and Technical Developments
    • 5.2.5 Emergence of Liquid Biopsy Solutions
    • 5.2.6 Targeting Anti-Biotic Resistance
    • 5.2.7 Decentralization of Diagnostic Testing
  • 5.3 Challenges
    • 5.3.1 High Initial Cost
    • 5.3.2 Obligation Of Skilled Labor
    • 5.3.3 Urgent Need for Proper Infrastructure

6. Competitive Landscape

  • 6.1 Global IVD Market
    • 6.1.1 Global IVD Kit Market Share by Company
  • 6.2 Global Molecular Diagnostics Market
    • 6.2.1 Global Molecular Diagnostics Market Share by Company
    • 6.2.2 Global Infectious Disease Testing Market Share by Company
    • 6.2.3 Global Blood Screening Testing Market Share by Company
    • 6.2.4 Revenue and Market Cap Comparison

7. Company Profiles

  • 7.1 Roche Holding AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Abbott Laboratories
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Danaher Corporation
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 Hologic Inc.
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies

List of Charts

  • IVD Market - Segments by Technology
  • Molecular Diagnostics - Traditional Process
  • Molecular Diagnostics Breakdown
  • Main Purposes of Molecular Diagnostics
  • Global IVD Market by Value (2013-2017)
  • Global IVD Market Forecast by Value (2018-2022)
  • Global IVD Market by Segment (2017)
  • Global IVD Market CAGR by Technology (2013-2017)
  • Global Molecular Diagnostics Market by Value (2013-2017)
  • Global Molecular Diagnostics Market Forecast by Value (2018-2022)
  • Global Molecular Diagnostics Market by Application (2017)
  • Global Infectious Disease Testing Market by Value (2013-2017)
  • Global Infectious Disease Testing Market Forecast by Value (2018-2022)
  • Global Infectious Disease Testing Market Value by Type (2017)
  • Global CT/NG Market by Value & Volume (2013-2017)
  • Global CT/NG Market Forecast by Value & Volume (2018-2022)
  • Global HPV Market by Value & Volume (2013-2017)
  • Global HPV Market Forecast by Value & Volume (2018-2022)
  • Global Oncology Testing Market by Value (2013-2017)
  • Global Oncology Testing Market Forecast by Value (2018-2022)
  • Global Blood Screening Testing Market by Value (2013-2017)
  • Global Blood Screening Testing Market Forecast by Value (2018-2022)
  • Global Genetic Testing Market by Value (2013-2017)
  • Global Genetic Testing Market Forecast by Value (2018-2022)
  • Global Molecular Diagnostics Market by Technology (2017)
  • Global Molecular Diagnostics Market by Region (2017)
  • North America Molecular Diagnostics Market by Value (2013-2017)
  • North America Molecular Diagnostics Market Forecast by Value (2018-2022)
  • North America Molecular Diagnostics Market by Application (2017)
  • North America Oncology Based Molecular Diagnostics Market by Value (2013-2017)
  • North America Oncology Based Molecular Diagnostics Market Forecast by Value (2018-2022)
  • North America Oncology Based Molecular Diagnostics Market by Product (2017)
  • North America Oncology Based Reagents Market by Value (2013-2017)
  • North America Oncology Based Reagents Market Forecast by Value (2018-2022)
  • North America Oncology Based Instruments Market by Value (2013-2017)
  • North America Oncology Based Instruments Market Forecast by Value (2018-2022)
  • Western Europe Molecular Diagnostics Market by Value (2013-2017)
  • Western Europe Molecular Diagnostics Market Forecast by Value (2018-2022)
  • Western Europe Molecular Diagnostics Market by Application (2017)
  • Asia Pacific Molecular Diagnostics Market by Value (2013-2017)
  • Asia Pacific Molecular Diagnostics Market Forecast by Value (2018-2022)
  • Asia Pacific Molecular Diagnostics Market by Application (2017)
  • Worldwide Ageing Population 60 Years or Older (2000-2030E)
  • Global Cancer Prevalence (2016-2021)
  • Global Healthcare Expenditure Per Capita (2013-2017)
  • Global Sample-to-Answer Molecular Diagnostics Market Value (2013-2017)
  • Global POCT Device Sales (2012-2017)
  • Global IVD Kit Market Share by Company (2017)
  • Global Molecular Diagnostics Market Share by Company (2017)
  • Global Infectious Disease Testing Market Share by Company (2017)
  • Global Blood Screening Testing Market Share by Company (2017)
  • Roche Sales by Segments (2017)
  • Roche Sales and Net Income (2013-2017)
  • Abbott Laboratories Sales by Segment (2017)
  • Abbott Laboratories Net Sales and Net Earnings (2013-2017)
  • Abbott Laboratories R&D Expenditure (2015-2017)
  • Danaher Corp. Revenue by Segments (2017)
  • Danaher Corp. Revenue and Net Earnings (2013-2017)
  • Danaher Corp. R&D Expenditure (2015-2017)
  • Hologic's Revenue by Business Segments (2018)
  • Hologic Inc. Revenue and Net Income (2014-2018)
  • Hologic Inc. R&D Expenditure (2016-2018)

List of Tables

  • The US approvals for CD Reagents
  • Growing Cases and Prevalence of STDs in the US (2010-2017)
  • Global Medical Equipment/Devices Sales (2016/2022)
  • Key Players - Revenue & Market Cap Comparison (2017)
  • Roche Agreements (2017/2018)
  • Roche Product Approvals (2018)
  • Hologic Inc. Product Launches (2018)
Back to Top